A Case Report of Donnai Barrow Syndrome: First Gross Deletion Mutation in LRP2 Gene


Creative Commons License

Kesriklioğlu B., Karaca Doğan B., Arslan Ateş E., Firtina S.

14th Balkan Congress of Human Genetics & 9th Rare Disease SEE Meeting 2023, Skopje, Makedonya, 5 - 07 Ekim 2023, ss.70, (Özet Bildiri)

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: Skopje
  • Basıldığı Ülke: Makedonya
  • Sayfa Sayıları: ss.70
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

A CASE REPORT OF DONNAI BARROW SYNDROME: FIRST GROSS DELETION MUTATION IN LRP2 GENE

Betül Kesriklioğlu, Beyza Karaca Doğan, Esra Arslan Ateş, Sinem Fırtına

Department of Medical Genetics, Cerrahpasa Medical Faculty, Istanbul University - Cerrahpasa, Istanbul, Turkey

Donnai-Barrow Syndrome (DBS)/ Facioculoacousticorenal (FOAR) Syndrome is a multiple congenital malformation syndrome characterized by typical facial dysmorphism, ocular findings, hearing loss, agenesis of the corpus callosum, low-molecular-weight proteinuria and variable intellectual disability. DBS is an autosomal recessive disorder caused by loss of function variants in the LRP2 (low-density lipoprotein receptor-related protein 2) gene (2q31.1) encoding the protein megalin, an endocytic transmembrane glycoprotein. We present a case with a deletion in exons 17-19 of the LRP2 gene with optic disc hypoplasia, pigmentary retinopathy, corpus callosum hypoplasia, developmental delay, growth retardation, hypothroidism, bilateral hypoplastic kidney and proteinuria in addition to dysmorphic findings compatible with DBS. We performed whole exome sequencing (WES), karyotype and microarray analysis for diagnosis and validated the exon 17-19 deletion with PCR. Karyotype and microarray analysis from peripheral blood were normal. No reads were observed between exons 17 and 19 of the LRP2 gene in WES analysis. These exons could not be amplified with PCR. Then, we amplified exon 16-20 with long PCR from cDNA samples of the patients and the parents for validation. We observed deletion in exon 17-19 region in patient’s sample when loaded into the gel electrophoresis.

Small deletions or insertions causing frameshifts, as well as conserved splice site, nonsense and missense mutations of LRP2 gene in DBS/FOAR families were reported before. We report the first case of gross deletion in LRP2 in a patient clinically diagnosed with DBS.

Keywords: Donnai Barrow Syndrome, LRP2 gene, Gross deletion, Whole exome sequencing, Gel electrophoresis